Gilead Sciences · 3 weeks ago
Associate Director, Strategic Planning and Operational Excellence - Portfolio Strategy, Insights and Analytics
United States - California - Santa Monica
Full-time
Onsite
Senior Level, Lead/Staff, Director/Executive
$178K/yr - $230K/yr
6+ years expGilead Sciences, through its Kite division, is focused on curing cancer with innovative therapies. The Associate Director will drive operational excellence and capability development while partnering with various teams to enhance portfolio management and strategic planning efforts.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Develop, enhance, and manage portfolio committee operations, including governance frameworks, meeting structures, and content preparation
Support semi-annual Kite and Gilead Portfolio Reviews, ensuring alignment with corporate strategic goals
Drive continuous capability development/enhancements in support of Portfolio Strategy and Portfolio Committee
Standardize processes and methodologies, including NPV modeling, productivity assessments, and PTRS across product teams
Design, deploy, and maintain business analytics and reporting capabilities that will ensure transparent and informed decision making across the Kite portfolio
Define and track key performance metrics to enable transparency and accountability
Facilitate alignment across stakeholders to ensure execution of strategic objectives
Partner with Clinical Development to manage and track development milestones across programs
Collaborate with Product Team Leads to support Kite and Gilead portfolio reviews
Partner with Gilead Portfolio Strategy & Analytics team to identify, prioritize, and implement areas to harmonization and standardization
Qualification
Required
Advanced scientific degree (i.e., MD, PharmD, PhD) and 6+ years of experience in Portfolio Management, Strategy, Business Operations, or related functions within biopharma or similar industry OR
Master's Degree and 8+ years of experience in Portfolio Management, Strategy, Business Operations, or related functions within biopharma or similar industry OR
Bachelor's Degree and 10+ years of experience in Portfolio Management, Strategy, Business Operations, or related functions within biopharma or similar industry OR
High School Degree and 12+ years of experience in Portfolio Management, Strategy, Business Operations, or related functions within biopharma or similar industry
Preferred
MBA, PhD, or scientific background preferred
3 - 5 years at top consulting firm a plus
Strong understanding of drug development and corporate governances
Experience influencing senior leaders and teams through communication and facilitation skills
Demonstrated ability to lead across a matrixed cross-functional team
Thorough analytical skills, including quantitative modeling and complex problem-solving ability
Strong collaboration, relationship building, and interpersonal skills
Adaptability within an agile environment and willingness to perform varying duties depending on the shifting needs of the business
Ability to work autonomously and under minimal supervision
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
10001+ employees
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2026-01-08
2026-01-07
2026-01-06
Company data provided by crunchbase